Curanex Pharmaceuticals Inc Common Stock (CURX NASDAQ) stock market data APIs
$0.2753
-0(-0%)
as of February 6, 2026
Try our APIs with
free plan!
Curanex Pharmaceuticals Inc Common Stock Financial Data Overview
Price chart is built with
Anychart
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Prev. Close
0.2753
Open
0.275
High
0.2897
Low
0.2637
52 wk Range
0.2651-9.18
Market Cap
7 595 K
Shares Outstanding
28 341 K
EPS
-0.04
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Curanex Pharmaceuticals Inc Common Stock data using free add-ons & libraries
Get Curanex Pharmaceuticals Inc Common Stock Fundamental Data
Curanex Pharmaceuticals Inc Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-17
- EPS/Forecast: NaN
Get Curanex Pharmaceuticals Inc Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Curanex Pharmaceuticals Inc Common Stock News
New
Catalyst Watch: Santa Claus Effect, M&A votes on Electronic Arts and TrueCar, index shuffling
[Futuristic display screen with a bar graph and colorful spreadsheet financial data] matejmo Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stan...
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discov...
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and...
Curanex Pharmaceuticals announces pricing of its initial public offering
* Curanex Pharmaceuticals (NASDAQ:CURX [https://seekingalpha.com/symbol/CURX]) announced on Tuesday the pricing of its initial public offering of 3.75 million shares of common stock at a public offe...
Get Curanex Pharmaceuticals Inc Common Stock fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
